In addition, immune checkpoints like CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) and PD-1 (programmed cell death protein 1) are critical for immune response regulation, and their upregulation on tumor cells can lead to adaptive immune resistance. This evidence concerns the gene PDCD1 and neoplasm.